Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Courage Therapeutics Inc
Profile last edited on: 10/28/2021      CAGE: 8EUM2      UEI: W841GEJ8ADX7

Business Identifier: new medicines for eating disorders
Year Founded
2019
First Award
2020
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

64 Homer Street
Newton, MA 02459
   N/A
   N/A
   www.couragetx.com
Location: Single
Congr. District: 04
County: Middlesex

Public Profile

Courage Therapeutics Inc, spun out of the University of Michigan, develops therapeutics to treat eating disorders. The firm has expertise in melanocortin receptor biology and are identifying and commercializing peptides and small molecules for GPCR targets. Anorexia Nervosa is the primary eating disorder the firm is focused on, aiming to make recovery faster and easier.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
1
Conversion Rate
50.00%
Phase I Dollars
$495,443
Phase II Dollars
$806,879
Total Awarded
$1,302,322

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 2 NIH $1,914,458
Project Title: Development of Melanocortin-3 Receptor Peptide Antagonists for the Treatment of Obesity and Maintenance of Weight Loss
2021 1 NIH $250,538
Project Title: Development of Melanocortin-3 Receptor Peptide Agonists for the Treatment of Anorexia Nervosa

Key People / Management

  Dan Housman -- CEO

  Roger Cone -- Founder

  Fred Mermelstein

  Tomui K Sawyer -- Head of Drug Discovery

Company News

Mar 24 2021
Courage Therapeutics Raises $1M for Treatment of Anorexia Nervosa and Other Related Eating Disorders